Deep sequencing of breakthrough infections from the AMP trials shows that prophylactic VRC01 selected for low-frequency HIV ...

A widespread failure to validate research antibodies before use is estimated to lead to the avoidable waste of millions of ...

Vial, a clinical-stage biotechnology company, today announced that it has dosed the first patient in its Phase 1b clinical ...

A new cryo-EM and biophysical study shows that removing the N153 glycan from dengue virus 2 exposes previously hidden ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Scientists calculated the massive human and animal sample loss caused by poorly characterized research antibodies and ...

Crimean-Congo hemorrhagic fever virus (CCHFV) is a dangerous virus spread by ticks. It transmits Crimean-Congo hemorrhagic fever (CCHF), a serious disease that has been spreading into new regions ...

Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the antibody response ...

Researchers in Switzerland have conducted the first systematic study that demonstrated that even small variations in a person’s genome can disrupt the therapeutic effects of monoclonal antibodies. “We ...

Video above: Companies test antibody drugs to treat COVID-19Antibodies that people make to fight the new coronavirus last for at least four months after diagnosis and do not fade quickly as some ...